Diagnosis & Early DetectionCan a Mother's Autoimmune Disease During Pregnancy Affect a Child's Type 1 Diabetes Risk?Research, trials, devices, and safety notices — labeled by evidence strength so you can tell solid science from hype.
1537 evidence-labeled articles across 6 topics
A clinical trial is testing tegoprubart, a targeted immunotherapy, alongside islet cell transplants in people with type…
Read →
A new clinical trial found that closed-loop insulin systems help pregnant women with type 1 diabetes spend more time in…
Read →
A new study from Japan suggests that adults with Type 1 diabetes who follow low-carbohydrate eating patterns—especially…
Read →A large Swedish study examined whether maternal autoimmune conditions during pregnancy influence whether children develo…
Read →
Scientists have discovered that regulatory T cells—the immune cells meant to protect the pancreas—become unstable and in…
Read →
A new study reveals that midlife adults with Type 1 diabetes experience conflicting motivations about exercise. Understa…
Read →Pulled from official registries and public research sources, then labeled by evidence strength before publication.
Saved on this device only. Matching items rise on Today. No health profile required.
29 items from 4 live sources. Feed checked Oct 26, 2026, 5:17 PM GMT-5.
Some MiniMed Flex insulin pumps were released with missing (i.e., devices with no result or abort test results are presumed to have failed) or failed verification test results in one or more of 9 functional tests. The unverified/failed pumps released to users potentially have one or more of the following issues: inoperable pump at setup, lack of protection for moisture exposur... Action: On 08/20/2026, Technical Support called affected customers to inform that, MiniMed identified an issue in which certain MiniMed...
A beta (early-release) version of the iOS application, version 2.13 (TestFlight) had a software issue preventing successful pairing of the t:slim application with Abbott FreeStyle Libre 3 Plus (FSL3P) continuous glucose monitoring (CGM) sensors, resulting in the insulin pump being unable to establish a near-field communication (NFC) connection with the CGM and requiring FSL3P... Action: On 07/16/2026, an "URGENT MEDICAL DEVICE CORRECTION" communication was sent via certified mail to customers informing them that a...
RECRUITING. Locations: Changsha, Hunan, China. To analyze the environmental risk factors for type 1 diabetes in China.
RECRUITING, PHASE2. Interventions: Rezpegaldesleukin, Placebo. Locations: San Francisco, California, United States | Aurora, Colorado, United States | New Haven, Connecticut, United States. This Phase 2 study is a 2-arm, multi-center, double-masked (masking of the participant, care provider and investigator), placebo-controlled, 2:1 randomized trial design in new onset T1D participants (within 100 days of diagnosis). Participants will be administered rezp...
RECRUITING. Locations: Vienna, Austria | Leuven, Belgium | Prague, Czechia. The purpose of INNODIA DETECT is to identify people who are at increased risk of developing T1D. Investigators are doing this by testing for markers in the blood (autoantibodies) that tell them an individuals risk of getting T1D in the future. What is Type 1 Diabetes (T1D)? T1D is a serious disease where the blood glucose (sugar) level is too high because the body cannot make a ho...
Loaner insulin pumps may have been cleaned with chemically incompatible products that could damage the pump case or keypad, allow moisture ingress, and result in insulin over- or under-delivery, potentially causing hypoglycemia, hyperglycemia, or diabetic ketoacidosis. Action: On 7/13/2026, field safety notices were sent to customers asking them to do the following: 1) Stop using the loaner pump and contact the firm to arrange for loaner pump return. 2) Contact your Healthcare Professional (H...
Loaner insulin pumps may have been cleaned with chemically incompatible products that could damage the pump case or keypad, allow moisture ingress, and result in insulin over- or under-delivery, potentially causing hypoglycemia, hyperglycemia, or diabetic ketoacidosis. Action: On 7/13/2026, field safety notices were sent to customers asking them to do the following: 1) Stop using the loaner pump and contact the firm to arrange for loaner pump return. 2) Contact your Healthcare Professional (H...
Loaner insulin pumps may have been cleaned with chemically incompatible products that could damage the pump case or keypad, allow moisture ingress, and result in insulin over- or under-delivery, potentially causing hypoglycemia, hyperglycemia, or diabetic ketoacidosis. Action: On 7/13/2026, field safety notices were sent to customers asking them to do the following: 1) Stop using the loaner pump and contact the firm to arrange for loaner pump return. 2) Contact your Healthcare Professional (H...
For MiniMed Go app version 1.0.0 and 1.1.0, when the Set day and night is turned OFF and missed dose or Correct high glucose alerts are enabled, the associated alerts will not be triggered during the nighttime. This could result in missed rapid-acting insulin doses without the user s knowledge, and may lead to delayed therapy and an increased risk of hyperglycemia. Action: On 6/16/2026 In-App Push Notifications were sent to customers entitled, Important Field Safety Corrective Action required on your MiniMed Go ap...
A software anomaly can occur when the pump is paired with the Instinct sensor. Under certain circumstances, the pump unexpectedly stops delivering insulin and displays two error messages back-to-back: Pump Error 53 followed immediately by Pump Error 23. Insulin delivery will stop which may lead to delayed therapy and an increased risk of hyperglycemia or diabetic ketoacidosis... Action: On 5/27/2026, field safety notices were emailed to customers who were asked to do the following: 1) Update insulin pump software...
External soft cannula damage during manufacturing that results in insulin leaking around the Pod instead of being delivered to the user regardless of basal or bolus delivery. The primary failure mode is pump under-delivery due to loss of insulin to an external leak. If insulin is not delivered properly, users may experience high blood glucose levels due to under-delivery of in... Action: Insulet initially issued a press release on 05/26/2026 along with an "Urgent: Medical Device Correction" on the same day. Consig...
External soft cannula damage during manufacturing that results in insulin leaking around the Pod instead of being delivered to the user regardless of basal or bolus delivery. The primary failure mode is pump under-delivery due to loss of insulin to an external leak. If insulin is not delivered properly, users may experience high blood glucose levels due to under-delivery of in... Action: Insulet initially issued a press release on 05/26/2026 along with an "Urgent: Medical Device Correction" on the same day. Consig...
Daily briefings, device safety watches, trial roundups, and research notes — each linked back to original sources.
A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.
A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.
A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.
A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.
breakthrought1d.org
A clinical trial is testing tegoprubart, a targeted immunotherapy, alongside islet cell transplants in people with type 1 diabetes who also have reduced kidney function—a group previously excluded from this treatment.
prnewswire.com
For the first time, a clinical trial is testing islet cell transplantation in people living with both type 1 diabetes and chronic kidney disease. The study uses a gentler immunosuppressive drug designed to reduce kidney damage.
medscape.com
New clinical guidelines aim to identify people in the autoimmune stage of Type 1 diabetes years before they develop symptoms. The framework standardizes screening and monitoring to catch the disease earlier and improve long-term outcomes.
GlobeNewswire News Room
The experimental immunotherapy, designed to modify disease progression in newly diagnosed Type 1 diabetes, has been granted expedited FDA review status. The move reflects regulatory recognition of an unmet medical need in the Type 1 diabetes community.
New Shorts daily on YouTube and TikTok
New Study Maps Autoantibody Patterns in Adult-Onset Type 1 Diabetes
New Study Maps Autoantibody Patterns in Adult-Onset Type 1 Diabetes
How One Hospital is Using CGM Technology to Improve Insulin Dosing in Children
How One Hospital is Using CGM Technology to Improve Insulin Dosing in Children
Reading the Metabolic Code: How Scientists Are Uncovering Type 1 Diabetes' Hidden Signals
Reading the Metabolic Code: How Scientists Are Uncovering Type 1 Diabetes' Hidden Signals
Scientists Develop a More Stable Form of Glucagon to Treat Severe Low Blood Sugar
Scientists Develop a More Stable Form of Glucagon to Treat Severe Low Blood Sugar
Study Finds Depression More Common in Type 1 Diabetes Than Type 2
Study Finds Depression More Common in Type 1 Diabetes Than Type 2
Exploring Rare Breast Inflammation: What BRCA Mutations and Type 1 Diabetes May Share
Researchers found a possible link between breast cancer genes and a rare inflammation tied to Type 1 diabetes.
New Research Shows Continuous Glucose Monitoring Works Well During Pregnancy With Diabetes
New Research Shows Continuous Glucose Monitoring Works Well During Pregnancy With Diabetes
A New Framework for Finding Type 1 Diabetes Before Symptoms Appear
A New Framework for Finding Type 1 Diabetes Before Symptoms Appear
Updated daily from ClinicalTrials.gov
Showing 6 of 8 programs tracked
Track all 8 programs →Chapter 5 — Age 17
“Closing in on seventeen, here's the short version of everything the younger me needed to hear.”
Closing in on seventeen, here's the short version of everything the younger me needed to hear.
Brooke's chapters are personal lived experience shared to make people feel less alone. They are not medical advice and do not describe a treatment plan. Talk to your own care team about your numbers, devices, and decisions.
If FDA, MedWatch, or a manufacturer issues a relevant CGM, pump, app, insulin, or glucagon alert, it should bypass the normal feed and hit the family alert lane first.
Medtronic MiniMed, Inc.
Some MiniMed Flex insulin pumps were released with missing (i.e., devices with no result or abort test results are presumed to have failed) or failed verification test results in one or more of 9 functional tests. The unverified/failed pumps released to users potentially have one or more of the following issues: inoperable pump at setup, lack of protection for moisture exposur... Action: On 08/20/2026, Technical Support called affected customers to inform that, MiniMed identified an issue in which certain MiniMed...
Open alertTandem Diabetes Care, Inc.
A beta (early-release) version of the iOS application, version 2.13 (TestFlight) had a software issue preventing successful pairing of the t:slim application with Abbott FreeStyle Libre 3 Plus (FSL3P) continuous glucose monitoring (CGM) sensors, resulting in the insulin pump being unable to establish a near-field communication (NFC) connection with the CGM and requiring FSL3P... Action: On 07/16/2026, an "URGENT MEDICAL DEVICE CORRECTION" communication was sent via certified mail to customers informing them that a...
Open alertMedtronic MiniMed, Inc.
Loaner insulin pumps may have been cleaned with chemically incompatible products that could damage the pump case or keypad, allow moisture ingress, and result in insulin over- or under-delivery, potentially causing hypoglycemia, hyperglycemia, or diabetic ketoacidosis. Action: On 7/13/2026, field safety notices were sent to customers asking them to do the following: 1) Stop using the loaner pump and contact the firm to arrange for loaner pump return. 2) Contact your Healthcare Professional (H...
Open alertMedtronic MiniMed, Inc.
Loaner insulin pumps may have been cleaned with chemically incompatible products that could damage the pump case or keypad, allow moisture ingress, and result in insulin over- or under-delivery, potentially causing hypoglycemia, hyperglycemia, or diabetic ketoacidosis. Action: On 7/13/2026, field safety notices were sent to customers asking them to do the following: 1) Stop using the loaner pump and contact the firm to arrange for loaner pump return. 2) Contact your Healthcare Professional (H...
Open alert